MyAverix Finance
F · Healthcare
Anavex Life Sciences Corp (12X1)
Biotechnology
Anavex Life Sciences Corp (12X1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 12X1
Anavex Life Sciences Corp (12X1) — FAQ
What is 12X1's P/E ratio?
The price-to-earnings (P/E) ratio for Anavex Life Sciences Corp (12X1) is 18.00 (data as of 2026-03-22).
Does Anavex Life Sciences Corp pay a dividend?
Dividend yield is not available in the current snapshot for Anavex Life Sciences Corp (12X1). Check the MyAverix Finance app for the latest dividend data.
What sector is Anavex Life Sciences Corp in?
Anavex Life Sciences Corp (12X1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 12X1 listed on?
12X1 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.